Multi-center randomized study of prophylactic effect of Landiorol for prevention of atrial fibrillation after cardiac surgery.
Not Applicable
Recruiting
- Conditions
- Atrial fibrillation after cardiac surgery
- Registration Number
- JPRN-UMIN000004433
- Lead Sponsor
- Graduate school of medical sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Cardiogenic shock, chronic atrial fibrillation, bronchial asthma, pulmonary hypertension, untreated pheochromocytoma, severe bradycardia including A-V block more than II degree, severe allergy to Landiorol, a judgement of attending physician that patient participation would be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of atrial fibrillation after cardiac surgery
- Secondary Outcome Measures
Name Time Method Degree and frequency of adverse events(death, stroke, MI, LOS, severe bradycardia, severe hypotension or decrease of CI)